SCHEMBL22071863

SCHEMBL22071863

CC(C)Oc1ccc(Nc2cc(-c3ccc(OC(C)C)cc3)c(CO)cc2N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 1/20 0.42
P2RX3 P56373 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
GLA P06280 1/20 0.40
PRMT3 O60678 2/20 0.39
CARM1 Q86X55 2/20 0.39
PRMT6 Q96LA8 2/20 0.39
PRMT1 Q99873 2/20 0.39
PRMT8 Q9NR22 2/20 0.39
MAPT P10636 5/20 0.38
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
TP53 P04637 2/20 0.38
MAP4K4 O95819 1/20 0.38
CSF1R P07333 1/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19781130 0.83 ACP1 (0.42) ACP1P2RX3GLAPRMT3CARM1
SCHEMBL22072403 0.81 ACP1 (0.46) ACP1P2RX3GLAPRMT3CARM1
SCHEMBL22072402 0.80 KDM4E (0.44) ACP1GLAMAPTALDH1A1GAA
SCHEMBL19781774 0.77 ACP1 (0.45) ACP1P2RX3GLAMAPTALDH1A1
SCHEMBL19781252 0.72 GLA (0.41) ACP1P2RX3GLAMAPTALDH1A1
SCHEMBL22032880 0.72 ACP1 (0.41) ACP1P2RX3GLAMAPTALDH1A1
SCHEMBL22072401 0.72 MAPT (0.46) ACP1P2RX3GLAMAPTALDH1A1
SCHEMBL19781521 0.70 GLA (0.42) ACP1P2RX3GLAMAPTALDH1A1
SCHEMBL15213071 0.70 P2RX3 (0.43) ACP1P2RX3GLAMAPTALDH1A1
SCHEMBL22033693 0.70 P2RX3 (0.43) ACP1P2RX3GLAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020117794-A1 COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION ARISAN THERAPEUTICS, INC. (US) 2020-06-11 WO disclosed